Streetbeat News

Stock Prices

BTCUSD

Peter Schiff criticizes the recommendation of Bitcoin ETFs over gold assets on CNBC's Fast Money, despite gold's record high. He suggests April could be a strong month for gold and miners, contrasting with Bitcoin ETFs' worst day since their launch. Bitcoin has surged 67% since the start of 2024, while gold has risen 8.25%. Schiff, a gold advocate, warns of a potential credit bubble and criticizes CNBC's Bitcoin coverage.

Portfolio Pulse from Benzinga Neuro

March 29, 2024 | 1:48 am

BTCUSD

DOGEUSD

Dogecoin (DOGE) experienced a 14% increase to $0.22, influenced by Bitcoin's (BTC) surge past $70,000 and optimism from Elon Musk's payment company's expansion. Dogecoin's market cap exceeded $30 billion, marking a significant milestone. Bitcoin's rally is attributed to demand following the approval of spot bitcoin ETFs, despite recent outflows. The crypto market rebounded after dovish remarks from the Federal Reserve. Additionally, Bitcoin spot ETFs and BlackRock's iShares Bitcoin Trust saw significant inflows, indicating growing confidence in Bitcoin.

Portfolio Pulse from Henry Khederian

March 29, 2024 | 1:47 am

PLUR

Trading for PLUR was halted at 7:50:00 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:50 pm

SHCR

Sharecare (NASDAQ:SHCR) reported Q4 earnings with an EPS of $-0.03, beating estimates by 50% but with a revenue decrease of $17.99M from the previous year. Despite beating EPS estimates in past quarters, such performance has previously led to a 2.0% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:55 pm

PIII

P3 Health Partners (NASDAQ:PIII) reported Q4 earnings with an EPS of $-0.22, missing estimates by -100.0% against an expected $-0.11. Revenue increased by $88.66 million from the same period last year. Despite missing this quarter's earnings estimate, the company had previously beaten EPS estimates in Q3 2023, which led to a 6.0% share price increase the following day.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:45 pm

AREC

American Res (NASDAQ:AREC) reported Q4 earnings with an EPS of $-0.15, missing estimates by -275.0% against an expected $-0.04. Revenue decreased by $4.62 million from the previous year. Despite a positive performance in the previous quarter leading to a 31.0% share price increase, this quarter's results were disappointing.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:45 pm

WATT

Energous (NASDAQ:WATT) reported Q4 earnings with a loss of $(0.74) per share, surpassing the $(0.85) estimate, marking a 47.14% improvement year-over-year. However, their sales of $91.67K fell short of the $200.00K estimate, a 48.84% decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 28, 2024 | 9:38 pm

MNST

Over the past 10 years, Monster Beverage (NASDAQ:MNST) has outperformed the market with an average annual return of 17.71%, turning a $100 investment into $500.61. The company now has a market capitalization of $62.00 billion.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:30 pm

ACGL

Arch Capital Group (NASDAQ:ACGL) has delivered an average annual return of 16.03% over the past 20 years, turning a $1000 investment into $19,365.92 today. The company's market capitalization stands at $34.59 billion.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:30 pm

RKDA

Arcadia Biosciences (NASDAQ:RKDA) reported Q4 earnings with an EPS of $-2.1, beating estimates by 19.0% against an expected $-2.58. Revenue increased by $170 thousand from the same period last year. Despite beating EPS estimates last quarter, RKDA's share price dropped by 3.0% the following day. The company's past earnings performance shows a mixed trend with both beats and misses on EPS and revenue estimates.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 9:30 pm